🇺🇸 FDA
Pipeline program

609A

SSGJ-609-UND-US-I-01

Phase 1 small_molecule active

Quick answer

609A for Solid Tumors is a Phase 1 program (small_molecule) at Sunshine Biopharma with 2 ClinicalTrials.gov record(s).

Program details

Company
Sunshine Biopharma
Indication
Solid Tumors
Phase
Phase 1
Modality
small_molecule
Status
active

Clinical trials